Becton, Dickinson and Company (BDXB) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Franklin Lakes, NJ, United States. The current CEO is Thomas E. Polen Jr..
BDXB has IPO date of 2020-05-21, 77,000 full-time employees, listed on the NYSE, a market capitalization of $13.69B.
Becton, Dickinson and Company is a global leader in medical technology, developing, manufacturing, and distributing a comprehensive portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, and the pharmaceutical industry through three primary business segments: BD Medical, which provides IV catheters, infusion systems, syringes, diabetes care products, and medication management solutions; BD Life Sciences, which offers specimen collection, microbiology automation, molecular testing systems, and cell analysis instruments; and BD Interventional, which specializes in surgical products, grafts, and critical care devices. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton Dickinson operates worldwide to advance patient care and clinical outcomes across multiple healthcare settings.
